Clinical Trial Update: Clinical Trial of YH32367 in Patients With HER2 Positive Locally Advanced or Metastatic Solid Tumor [Phase 1, Phase 2]

View source ↗

Summary

The trial of YH32367 for HER2-positive solid tumors is in Phase 1/2 and currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumor

Drugs mentioned

• YH32367

Snippet

Sponsor: Yuhan Corporation | Conditions: HER2-Positive Solid Tumor | Phase 1, Phase 2 | Status: RECRUITING